Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Iveric bio
Pharma
Apellis counters Izervay results with long-term data of its own
Apellis Pharmaceuticals is putting up long-term data on Syfovre in a bid to outdo its new geographic atrophy rival Izervay.
Fraiser Kansteiner
Nov 6, 2023 3:53pm
Eric Stonestreet teams with Iveric Bio for eye disease campaign
Sep 21, 2023 9:15am
Astellas touts 2-year trial of Izervay, but questions remain
Sep 19, 2023 11:32am
FDA signs off on Astellas' recently acquired GA drug Izervay
Aug 7, 2023 11:16am
Astellas' new CEO takes over a company in transition
Jun 13, 2023 8:50am
Iveric to develop sustained-release form of retinal disease drug
Jul 5, 2022 10:00am
